The general conditions of use of the site are explained below. The purpose of this site is to present the activities and results of 4P-Pharma. Any visitor to the site admits to having read and accepts them. They do not release it from the obligations it contracts by accessing through a link to a third-party page or website. 4P-Pharma reserves the right to modify at any time these by changing its website.


All the data contained on the site including: images, animations, graphic charter, texts, logos, is protected by the legal provisions protecting intellectual property rights. Any reproduction, even partial, of any of the contents of our website is strictly prohibited without requesting authorization from 4P-Pharma. The logo and the domain name “” are protected names belonging to 4P-Pharma and you can not use them without the express and prior agreement of 4P-Pharma;


In order to comply with the General Data Protection Regulation (GDPR) implemented on May 25th 2018 in the European Union, we are updating our privacy policy.

The data collected for 4P-Pharma newsletter subscription (first and last name, company name and address, professional e-mail address and professional phone number) are considered as highly confidential and are collected and stored in a secured way. We are using these data exclusively within the aim to inform you and communicate about 4P-Pharma’s activities and recent news. We do not share your data with any other company or organization in any case.

By continuing to use our services beyond May 24th 2018, it will mean that you accept such conditions. If not, you can ask for deleting your data by writing to




Société par actions simplifiée

Address: Campus de l’Institut Pasteur de Lille- 1, rue du Professeur Calmette

59800 LILLE

RCS Lille Metropole B 804 204 071

Publication director: Revital Rattenbach, President




SAS au capital de 10 000 000 €

RCS Roubaix – Tourcoing 424 761 419 00045
Code APE 6202A
 N° TVA : FR 22 424 761 419

address : 2 rue Kellermann – 59100 Roubaix – France.

Publication director: Octave KLABA


Last update: February 2020